Simplify Propel Opportunities ETF (SURI) Research
The Simplify Propel Opportunities ETF (SURI) aims to deliver substantial long-term capital growth. It achieves this by investing in companies across the biotechnology, pharmaceutical, healthcare technology, and life sciences industries. These particular firms are selected because they are believed to be overlooked by investors, suggesting significant potential for their value to increase. Propel, the fund's sub-advisor, applies its deep scientific and commercial knowledge in health sciences to identify and select the most promising investment opportunities within this sector.
Market snapshot
- Symbol
- SURI
- Price
- $17.02
- Day change
- -1.94%
- Market cap
- $73.0M
- 52-week range
- 14.7-18.5
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- iShares BBB-B CLO Active ETF (BCLO)
- MarketDesk Focused U.S. Dividend ETF (FDIV)
- Leuthold Core Exchange Traded Fund (LCR)
- F/M Emerald Life Sciences Innovation ETF (LFSC)
- Miller Value Partners Appreciation ETF (MVPA)
- Pacer Swan SOS Moderate (October) ETF (PSMO)
- ProShares - Ultra Health Care (RXL)
- YieldMax TSM Option Income Strategy ETF (TSMY)
Open Simplify Propel Opportunities ETF (SURI) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.